Speaking on behalf of the pharmaceutical industry, Mr. Stetler does not believe that advertising unduly influences a physician's prescribing practices. Rather it provides him with new information to be further explored, usually in consultation with colleagues, and permits him to easily compare the claims of one product with others in the same therapeutic categories. The paper also outlines legislative proposals for controlling specific promotional practices which the industry deems unacceptable.
Get full access to this article
View all access options for this article.
References
1.
CluteK. F.1963The General Practitioner: A Study of Medical Education and Practice in Ontario and Nova Scotia. Toronto: University of Toronto Press.
2.
ColeJonathan O.1972“Drug Abuse—The Doctor's Dilemma.”Southern Medical Journal69:9.
3.
KallitArthur1970U.S. Medicine (January 13).
4.
KlineNathan S.1971“The Under-Medicated Patient.”American Association for the Advancement of Science (paper presented, Philadelphia, December 28).
5.
McGillReporter1975“Drug Doses Not Big Enough, Pharmacologist Claims.” (March 5).
6.
Pravda1966 (October 12).
7.
SimmonsHenry E.PaulD. Stolley1974“This Is Medical Progress?”Journal of the American Medical Association227:9.
8.
StolleyPaul D.1972“The Relationship Between Physician Characteristics and Prescribing Appropriateness.”Medical Care (January-February).
9.
WaxburgJ.1973“What Motivates a Physician to Try a New Product.”Medical Marketing and Media (July).
